STAT - Reporting from the frontiers of health and medicine

Health

Pharma

By Jessica Davis Plüss

Exclusive

Opinions Plus Building the perfect wearable for clinical trials
First Opinion No evidence that patents slow access to vaccines
Health When a cardiologist flagged the lack of diversity at premier medical journals, the silence was telling
Health On a limb: Despite resistance, a group of researchers is investigating the possibility of a new mental health disorder
Health Tech Amazon established a foothold in diagnostics during Covid-19. Now it’s doubling down

Daily, market-moving coverage of biotech and pharma

Inside intelligence on the NIH, the FDA, and Congress

Profiles of the power players shaping the industry

Analysis of the latest scientific developments

Microsoft to buy Nuance Communications for $19.7 billion
Federal agency says pharma should pay higher Medicaid rebates if certain trials aren’t finished on time
Clinical study reports hold more details about the side effects of cancer drugs

Health Tech

A STAT Investigation

A STAT Investigation

Biotech

In Memoriam

First Opinion Podcast

Health Comparing the Covid-19 vaccines developed by Pfizer, Moderna, and Johnson & Johnson
Health On a limb: Despite resistance, a group of researchers is investigating the possibility of a new mental health disorder
Special Report The story of mRNA: How a once-dismissed idea became a leading technology in the Covid vaccine race
Health The Covid-19 Tracker
Health 1 in 3 Covid-19 patients are diagnosed with a neuropsychiatric condition in the next six months, large study finds
Health When a cardiologist flagged the lack of diversity at premier medical journals, the silence was telling
Biotech Regeneron says antibody cocktail prevented Covid when given as simple injection, not an IV
Health Tech Google is exploring a health record tool for patients